Marché mondial de la surveillance des médicaments thérapeutiques – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et perspectives du marché mondial de la surveillance des médicaments thérapeutiques

Le marché de la surveillance thérapeutique des médicaments devrait connaître une croissance de 8,4 % au cours de la période de prévision de 2022 à 2029. Le rapport de recherche sur le marché de la surveillance thérapeutique des médicaments de Data Bridge fournit une analyse et des informations sur les différents facteurs qui devraient prévaloir tout au long de la période de prévision tout en fournissant leurs impacts sur la croissance du marché. L'essor du secteur de la santé à l'échelle mondiale accélère la croissance du marché de la surveillance thérapeutique des médicaments.

La surveillance thérapeutique des médicaments est un test qui consiste à mesurer différents médicaments dans la circulation sanguine pour s'assurer de la quantité administrée. Il vérifie si la quantité est suffisante pour être efficace et ne provoque pas de réactions majeures ou d'effets secondaires. Certains médicaments doivent être surveillés pour garantir leur sécurité et leur efficacité, comme les antiarythmiques, les antibiotiques, les antiépileptiques et les médicaments psychoactifs.

L'augmentation de la demande d'hôpitaux et d'établissements de soins médicaux à travers le monde constitue l'un des principaux facteurs de croissance du marché de la surveillance thérapeutique des médicaments. La grande importance de la surveillance thérapeutique des médicaments (TDM) dans les procédures de transplantation d'organes et l'augmentation de la préférence pour la médecine de précision accélèrent la croissance du marché. L'accent croissant mis sur les activités de recherche et développement liées à la surveillance thérapeutique des médicaments (TDM) et l'utilisation élevée du test de surveillance des médicaments dans divers domaines thérapeutiques influencent davantage le marché. En outre, les améliorations de l'industrie médicale, la croissance de la sensibilisation, les avancées technologiques et l'augmentation des investissements des sociétés pharmaceutiques ont un effet positif sur le marché de la surveillance thérapeutique des médicaments. En outre, l'augmentation de l'adoption dans le traitement des maladies auto-immunes étend les opportunités rentables aux acteurs du marché au cours de la période de prévision de 2022 à 2029.

On the other hand, requirement of high capital investments and availability of alternatives to conventional therapeutic drug monitoring market are expected to obstruct the market growth. The reluctance of small hospitals to offer TDM services, and operational barriers faced in conducting TDM tests are projected to challenge the therapeutic drug monitoring market in the forecast period of 2022-2029.

This therapeutic drug monitoring market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on therapeutic drug monitoring market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Therapeutic Drug Monitoring Market Scope and Market Size

The therapeutic drug monitoring market is segmented on the basis of product, technology, class of drugs, therapeutic areas and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

• On the basis of product, the therapeutic drug monitoring market is segmented into consumables and devices. Devices are further segmented into diagnostic devices and proteomic tools.
• On the basis of technology, the therapeutic drug monitoring market is segmented into in immunoassays and proteomic technologies. Immunoassays are further sub-segmented into cloned enzyme donor immunoassay, fluorescence polarization immunoassay, particle-enhanced turbidimetric immunoassay and chemiluminescent immunoassay. Proteomic technology is further segmented into liquid chromatography/ mass spectrometry and gas chromatography/ mass spectrometry.
• On the basis of class of drugs, the therapeutic drug monitoring market is segmented into psychoactive drug, bronchodilators, immunosuppresants, antibiotics, antiarrhythmic drugs and anti-neoplastic drugs.
• On the basis of therapy areas, the therapeutic drug monitoring market is segmented into alimentary tract and metabolism, blood and blood forming organs, cardiovascular disease, dermatological disease, genitourinary disease and sex hormones, hormonal preparations, anti-infectives, anti-neoplastic and immunomodulating, musculo-skeletal disease, nervous system disease, respiratory diseases and sensory organ disease.
• On the basis of end users, the therapeutic drug monitoring market is segmented into hospitals labs, labs and others.

Therapeutic Drug Monitoring Market Country Level Analysis

The therapeutic drug monitoring market is segmented on the basis of product, technology, class of drugs, therapeutic areas and end users.      

The countries covered in the therapeutic drug monitoring market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the therapeutic drug monitoring market because of the presence of technologically advanced healthcare infrastructure within the region. Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in investments in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The therapeutic drug monitoring market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for therapeutic drug monitoring market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the therapeutic drug monitoring market. The data is available for historic period 2010-2020.

Competitive Landscape and Therapeutic Drug Monitoring Market Share Analysis

Le paysage concurrentiel du marché de la surveillance thérapeutique des médicaments fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché de la surveillance thérapeutique des médicaments.

Français Certains des principaux acteurs opérant dans le rapport sur le marché de la surveillance thérapeutique des médicaments sont Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthcare Private Limited, Thermo Fisher Scientific, Abbott, Bayer AG, bioMérieux SA, Alere, Inc., Danaher, THERADIAG, Tecan Trading AG, SQI Diagnostics, SEKISUI MEDICAL CO., LTD, Spectra QEST, Myriad Genetics, Inc., Miraca Holdings, Inc, Merck KGaA, InSource Diagnostics, Exagen Inc, Euro Diagnostica AB, Diasorinb Spa et Adaptive Biotechnologies, entre autres.

SKU-20320